TGFB1 and breast carcinoma: Our findings could be supported by the findings of Sovak et al. [40], they indicated, in certain breast cancer cell lines, that TGF-β showed capabilities of suppressing NF-κB signalling through up-regulating the expression of IκBα and subsequently inhibit the NF-κB pathway.